Fish E W, Faccidomo S, Miczek K A
Department of Psychology, Tufts University, Medford, Massachusetts 02155, USA.
Psychopharmacology (Berl). 1999 Oct;146(4):391-9. doi: 10.1007/pl00005484.
Models of heightened aggression may be particularly relevant in exploring pharmacological options for the clinical treatment of aggressive and impulsive disorders.
To investigate and compare the effects of a 5-HT(1B) selective agonist, CP-94,253, on aggression that was heightened as a result of 1) social instigation or 2) alcohol treatment.
Male CFW mice were administered 1.0 g/kg EtOH and were subsequently confronted by an intruder in their home cage. In a separate experimental procedure, resident male mice were instigated to aggressive behavior by brief exposure to a provocative stimulus male. To test the hypothesis that activation of the 5-HT(1B )receptor subtype would preferentially attenuate heightened aggression, in comparison to the moderate levels of species-typical aggressive behaviors, the selective agonist, CP-94,253 (1.0-30 mg/kg, IP), and antagonists to the 5-HT(1B) (GR 127935; 10 mg/kg, IP) and the 5-HT(1A) receptor (WAY 100,635; 0.1 mg/kg IP) were used.
CP-94,253 suppressed non-heightened aggressive behavior (ED(50)=7.2 mg/kg ). GR 127935, but not WAY 100,635 shifted the ED(50) for CP-94,253 to 14.5 mg/kg. Importantly, the anti-aggressive effects of CP-94,253 were not accompanied by locomotor sedation. Alcohol-heightened and instigation-heightened aggression were suppressed at lower doses than those necessary to suppress non-heightened aggression (ED(50)=3. 8 and 2.7 mg/kg, respectively).
The current results support the hypothesis that activation of 5-HT(1B) receptors modulates very high levels of aggressive behavior in a pharmacologically and behaviorally specific manner.
在探索针对攻击性和冲动性障碍的临床治疗的药理学选择时,增强攻击性的模型可能特别相关。
研究并比较5-HT(1B)选择性激动剂CP-94,253对因以下两种情况而增强的攻击性的影响:1)社会煽动;2)酒精处理。
给雄性CFW小鼠腹腔注射1.0 g/kg乙醇,随后在其家笼中让一只入侵者与其对峙。在另一个实验程序中,通过短暂暴露于具有挑衅性的雄性刺激物来促使常驻雄性小鼠产生攻击行为。为了检验5-HT(1B)受体亚型的激活与物种典型攻击行为的中等水平相比会优先减轻增强的攻击性这一假设,使用了选择性激动剂CP-94,253(1.0 - 30 mg/kg,腹腔注射)以及5-HT(1B)拮抗剂(GR 127935;10 mg/kg,腹腔注射)和5-HT(1A)受体拮抗剂(WAY 100,635;0.1 mg/kg腹腔注射)。
CP-94,253抑制非增强的攻击行为(半数有效剂量[ED(50)] = 7.2 mg/kg)。GR 127935而非WAY 100,635将CP-94,253的ED(50)转变为14.5 mg/kg。重要的是,CP-94,253的抗攻击作用并未伴随运动性镇静。与抑制非增强攻击行为所需剂量相比,较低剂量的CP-94,253就能抑制酒精增强和煽动增强的攻击性(ED(50)分别为3.8和2.7 mg/kg)。
当前结果支持以下假设,即5-HT(1B)受体的激活以药理学和行为学上特定的方式调节非常高水平的攻击行为。